Connect Biopharma Holdings Ltd (CNTB) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Connect Biopharma Holdings Ltd (US:CNTB), trading at 2.09. In 2025, Connect Biopharma Holdings Ltd generated $64,000 in revenue and -$51.64 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Connect Biopharma Holdings Ltd is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 2.09
- Recent Revenue (2025): $64,000
- Free Cash Flow (2025): -$51.64 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.